Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc8.2 | Neuroendocrinology clinical | ECE2007

Effect of GH receptor antagonist pegvisomant on cardiovascular risk and atherosclerosis in acromegalic patients resistant to somatostatin analogues

De Martino Maria Cristina , Auriemma Renata S , Brevetti Gregorio , Galdiero Mariano , De Leo Monica , Lombardi Gaetano , Colao Annamaria , Pivonello Rosario

Acromegaly is known to be associated to an increased cardiovascular risk, due to the increased prevalence of glucose intolerance and dyslipidemia and pre-atherosclerotic lesions. The aim of this study was to evaluate the effect of treatment with the GH receptor antagonist pegvisomant on cardiovascular risk and atherosclerosis in patients with acromegaly resistant to somatostatin analogues. Twelve patients (4 m, 8 f, 28–58 yrs) and 24 sex-, age- and BMI-matched controls en...

ea0014p117 | (1) | ECE2007

A novel activating germline mutation in the RET gene (Y606C) in a patient with medullary thyroid carcinoma

Luconi Michaela , Ercolino Tonino , Lombardi Adriana , Becherini Lucia , Piscitelli Elisabetta , Sole Gaglianò Maria , Serio Mario , Mannelli Massimo

Germline mutations in the RET gene cause MEN2, an inherited cancer syndrome associated with medullary thyroid carcinoma (MTC). We performed genetic analysis on DNA from whole blood of a 58 yr old female affected by a multifocal MTC. Exons 10, 11, 13, 15 and 16 of RET gene were amplified by PCR using specific primers and characterised by direct automatic sequencing. Here, we report a new RET point mutation: a heterozigous missense mutation Y606C, a G to A nucleotide substitutio...

ea0014p548 | (1) | ECE2007

Effects of combined treatment with cabergoline and somatostatin analogues (SAA) on GH and IGF-I levels and tumor volume in patients with acromegaly not fully responsive to SAA

Auriemma Renata S , Galdiero Mariano , De Martino Maria Cristina , De Leo Monica , Lombardi Gaetano , Colao Annamaria , Pivonello Rosario

Dopamine agonists have been used as first or adjunctive therapy for acromegaly for many years, but relatively few studies have assessed the efficacy of a newer agonist, cabergoline (CAB) alone or in combination with somatostatin analogues (SSA). The aim of this study was to evaluate the efficacy of combined treatment with SSA plus CAB in patients with acromegaly and resistance to SSA, defined as lack of normalization of IGF-I levels after long-term (>1 year) and hig...

ea0014p633 | (1) | ECE2007

Three months exercise training improves cardiopulmonary functional capacity in polycystic ovary syndrome

Orio Francesco , Giallauria Francesco , Palomba Stefano , Cascella Teresa , Vuolo Laura , Tafuri Domenico , Manguso Francesco , Lombardi Gaetano , Colao Annamaria , Vigorito Carlo

Introduction and Aim: Polycystic Ovary Syndrome (PCOS) is an endocrine disease closely related to several risk factors for cardiovascular disease. Previous study demonstrated an impaired cardiopulmonary functional capacity in PCOS women. The present study was performed to evaluate the effects of 3-months exercise training (ET) programme on cardiopulmonary functional capacity in young women with PCOS.Patients and Methods: The study was conducted according...

ea0073aep21 | Adrenal and Cardiovascular Endocrinology | ECE2021

Metabolic and Inflammation markers in patients with mild autonomous cortisol secretion: preliminary results of a Randomized Clinical Trial

Morelli Valentina , Frigerio Sofia , Perego Silvia , Lombardi Giovanni , Aresta Carmen , Pugliese Flavia , Scillitani Alfredo , Arosio Maura , Corbetta Sabrina , Chiodini Iacopo

IntroductionIrisin is a molecule secreted from skeletal muscle and contributes to maintenance of metabolic homeostasis leading to increased energy expenditure and reducing the risk of obesity and diabetes. Literature data suggest that patients with Cushing disease have lower irisin values than controls and remission of hypercortisolism increases these values. Moreover, other plasma inflammation markers implicated in the pathogenesis of atherosclerosis, i...

ea0090p679 | Pituitary and Neuroendocrinology | ECE2023

Prevalence of steatosis and organ-specific distribution of adipose tissue in patients affected by Cushing’s syndrome

Ferrante Emanuele , Oberti Giovanna , Mantovani Beatrice , Indirli Rita , Cremaschi Arianna , Sala Elisa , Carosi Giulia , Ludovica Fracanzani Anna , Mantovani Giovanna , Lombardi Rosa , Arosio Maura

Introduction: Endogenous hypercortisolism is associated with cardio-metabolic complications and promotes the deposition of lipids in different tissues, particularly in the liver. However, the prevalence of hepatic steatosis in patients with Cushing’s syndrome (CS) has been little investigated so far and only one previous study reported a prevalence of 20% using computed tomography. The aim of the study is to evaluate the prevalence of hepatic steatosis and the organ-speci...

ea0070aep143 | Bone and Calcium | ECE2020

Osteocalcin may participate to the bone-parathyroid crosstalk through activation of the calcium-sensing receptor in human parathyroid adenomas

Verdelli Chiara , Stefania Tavanti Giulia , Maggiore Riccardo , Mari Gilberto , Sansoni Veronica , Perego Silvia , Vicentini Leonardo , Dalino Ciaramella Paolo , Lombardi Giovanni , Corbetta Sabrina

Parathyroid glands regulate bone metabolism through PTH, while bone modulates parathyroid function through calcium and FGF23. Bone releases the matrix protein osteocalcin (OC), whose hormone function is increasingly evident. We tested the hypothesis that OC may modulate parathyroid function. The 6 hours-stimulation of human parathyroid cells derived from adenomas (PAds) (n = 5) with γ-carboxylated OC (GlaOC; 40–60 ng/ml) increased the expression levels ...

ea0070aep611 | Pituitary and Neuroendocrinology | ECE2020

Effects of different therapeutic approaches on cardiovascular risk in patients with acromegaly: Results of a multicentric study

Reimondo Giuseppe , Spagnolo Federica , Puglisi Soraya , Lombardi Stocchetti Benedetta , Ragonese Marta , Ceccato Filippo , Ferraù Francesco , Berchialla Paola , Carla Scaroni , Cannavò Salvatore , Terzolo Massimo

The association between acromegaly and increased cardiovascular morbidity and mortality is widely recognised. The aim of this retrospective multicentric study is to evaluate the impact of different therapeutic approaches on the progression of cardiovascular risk (CVR) in acromegalic patients. At diagnosis and last follow up (follow up time of 13 ± 8 years),we assessed BMI, blood pressure, glycaemic and lipid profile, GH and IGF1 levels in 199 patients with acromegaly (116...

ea0029p125 | Adrenal medulla | ICEECE2012

Pheochromocytoma incidentally discovered after thyroid surgery manifesting dramatic hypertensive crisis induced by metoclopramide

Corsello S. , Ricciato M. , Paragliola R. , Bello G. , Bocci M. , De Crea C. , Raffaelli M. , Lombardi C. , Antonelli M. , Pontecorvi A. , Bellantone R.

Introduction: Metoclopramide is known to exert stimulatory effects on catecholamine secretion, having been used in the past as provocative test in the diagnosis of pheochromocytoma. We describe a patient with an incidentally discovered pheochromocytoma after metoclopramide administration.Case report: A 64 years-old woman underwent total thyroidectomy for multinodular goiter with ‘follicular proliferation Thy 3’ at FNAB of the target nodule. The...

ea0029p847 | Endocrine tumours and neoplasia | ICEECE2012

Clinical and morphological characterization of C cell hyperplastic and neoplastic lesions of thyroid

Lugli F. , Fusco A. , Bianchi A. , Milardi D. , Cimino V. , Piacentini S. , Celico M. , Lanza P. , Raffaelli M. , Lombardi C. , Fadda G. , Bellantone R. , Pontecorvi A. , Rindi G. , De Marinis L.

Introduction: Medullary thyroid carcinoma (MTC) and C cell hyperplasia (CCH) have a variable clinical presentation and prognosis and few data are available on the correlation between immunohistochemical characterization (IIC) and clinical behavior.Aim: We studied the clinical and morphological characterization of CCH and MTC and we evaluated IIC expression of PTTG-1, SSTR2A, VEGFR-1, VEGFR-2 and VEGFR-3 in 23 cases of CCH and/or MTC, correlating it with ...